AXSM
#880
Axsome Therapeutics, Inc. - Common Stock
206.2 7 USD
0.00%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.42%
Monthly Change
-12.56%
6 month change
+27.28%
Year Change
+58.43%
Previous Close
207.1 5
Open
206.2 7
Low
206.2 7
High
206.2 7
Volume
75
Financials
- Market Capitalization 10.8 B
- Employee 925
- Founded 2012
- CEO Herriot Tabuteau
- Website www.axsome.com
- Headquarter Delaware, United States
- FIGI BBG00B6G7GL7
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-49.63
Price to sales ratio
14.23
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 857 |  TECH Bio-Techne Corp - Common Stock | 72.47 USD | +0.12% | +0.19% | +0.47% | +33.83% | 11.36 B USD | ||
| 875 |  CYTK Cytokinetics, Incorporated - Common Stock | 77.90 USD | -1.64% | +0.78% | -2.34% | +34.08% | 10.83 B USD | ||
| 896 |  KRYS Krystal Biotech, Inc. - Common Stock | 357.46 USD | -0.64% | +5.93% | -1.23% | +91.02% | 10.58 B USD | ||
| 906 |  IONS Ionis Pharmaceuticals, Inc. - Common Stock | 62.43 USD | -1.47% | +4.68% | +13.32% | -13.44% | 10.37 B USD |
Frequently asked questions about Axsome Therapeutics, Inc
What is the Axsome Therapeutics, Inc stock price today?
The current price of Axsome Therapeutics, Inc (AXSM) is 206.27. Over the past 24 hours, the stock has changed by -0.42%. Follow the AXSM chart for real-time price dynamics.
What is the stock ticker of Axsome Therapeutics, Inc?
Axsome Therapeutics, Inc trades under the ticker AXSM. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Axsome Therapeutics, Inc stock going up?
AXSM has changed by -0.46% over the last week, -12.56% over the last month, and +58.43% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Axsome Therapeutics, Inc?
Axsome Therapeutics, Inc currently has a market capitalization of 10.8 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Axsome Therapeutics, Inc earnings last quarter?
Last quarter, Axsome Therapeutics, Inc reported earnings of -0.99 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Axsome Therapeutics, Inc revenue for the last quarter?
Axsome Therapeutics, Inc reported quarterly revenue of 218.38 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Axsome Therapeutics, Inc net income for the last quarter?
Axsome Therapeutics, Inc reported net income of -51.31 M for the last quarter. The previous quarter showed -64.54 M, which means net income changed by +20.50%.
How many employees does Axsome Therapeutics, Inc have?
As of the latest available data, Axsome Therapeutics, Inc has 925 employees. Workforce size can provide additional context about the company's scale and operations.
What is Axsome Therapeutics, Inc EBITDA?
Axsome Therapeutics, Inc EBITDA is -46.59 M, and its EBITDA margin is -21.34%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Axsome Therapeutics, Inc stock?
You can buy Axsome Therapeutics, Inc (AXSM) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Axsome Therapeutics, Inc stock?
Investing in Axsome Therapeutics, Inc requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AXSM chart and related analysis on metatrader.com as part of your research.